Head Of Inhaled Product Development (Interim)
Current
Apr 2024 - Present
AeroLeads people directory · profile
Dan Deaton Email & Phone Number
Head of Inhaled Product Development at AstraZeneca
at
AstraZeneca
1 work email found
@astrazeneca.com
1 phone found area 714
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Head of Inhaled Product Development at AstraZeneca
Location
Raleigh-Durham-Chapel Hill Area, United States, United States
Who is Dan Deaton? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Dan Deaton is listed as Head of Inhaled Product Development at AstraZeneca at AstraZeneca, based in Raleigh-Durham-Chapel Hill Area, United States, United States. AeroLeads shows a work email signal at astrazeneca.com, phone signal with area code 714, and a matched LinkedIn profile for Dan Deaton.
Dan Deaton previously worked as Head of Inhaled Product Development (Interim) at Astrazeneca and Executive Director Patient Experience and Innovation at Astrazeneca. Dan Deaton holds Msme, Mechanical Engineering from North Carolina State University.
Company email context
Email format at AstraZeneca
This section adds company-level context without repeating Dan Deaton's masked contact details.
{first}.{last}@astrazeneca.com
86% confidence
AeroLeads found 1 current-domain work email signal for Dan Deaton. Compare company email patterns before reaching out.
Profile bio
About Dan Deaton
Accomplished senior executive with 25+ years of experience in the pharmaceutical and medical device industries. Dedicated to improving patients' lives and experiences through the development and commercialization of innovative therapies and advanced delivery systems. Proven expertise in leading high-performing, agile teams to drive focused execution and accelerate delivery of novel combination drug products, delivery devices, and digital health technologies.Key Areas of Expertise:- Inhaled drug development, including clinical supply, global regulatory filings, and commercialization- Strategic development and portfolio management for pharmaceutical products and device technologies- Navigation of complex global regulatory and intellectual property (IP) landscapes- Innovation and portfolio processes to meet evolving needs for new technologies and new drug modalities to serve changing patient populations- Competitive analysis and business case development- Due diligence for new product and technology opportunities- Organizational and operational management and leadershipStrengths:- Building and leading high-performing teams with a focus on positive, energetic, and collaborative work cultures and external partnerships- Combining strong engineering and technical aptitudes with a deep appreciation for strategic business objectives- Technical expertise as a mechanical designer and inventor, developing a wide range of patient focused proprietary products including drug delivery devices, medical equipment and digital health solutions.- Track record of successful end-to-end development and commercialization of drug products and technologies focused on improving patient outcomes.
Listed skills include Medical Devices, Commercialization, Product Development, Cross Functional Team Leadership, and 19 others.
Current workplace
Dan Deaton's current company
Company context helps verify the profile and gives searchers a useful next step.
10 roles · 25 years
Dan Deaton work experience
A career timeline built from the work history available for this profile.
Executive Director Patient Experience And Innovation
Nov 2022 - Mar 2024
Senior Director Device Development
Apr 2017 - Nov 2022
Angel Investor
Current
Triangle Angel Partners (Tap)
Triangle Angel Partners is an experienced band of angel investors in the high tech and life sciences industries, interested in investing their time, analysis and money into early life cycle companies.
Sep 2011 - Present
Board Of Directors
Community Workforce Solutions, Inc. is dedicated to supporting persons with disabilities and other barriers to employment as each individual works to achieve his/her individually chosen employment and community integration goals.
Jan 2012 - Jun 2023
Board Director
Polarean designs and manufactures equipment for production of hyperpolarized xenon or helium gas. When used in conjunction with MRI, these gases offer a fundamentally new and non-invasive functional imaging platform. Current investigational uses include identifying early diagnoses of respiratory diseases as well as monitoring progression and therapeutic.
Oct 2011 - May 2017
Managing Director
We provide expertise, drive, and ingenuity to develop best in class healthcare products. We partner with clients ranging from new ventures to Fortune 500 companies who are seeking to respond to fast paced competition with precision and energy. Current areas of focus include connected healthcare and next generation drug delivery devices.
Nov 2013 - Apr 2017
Vice President Of Innovation
Ibiliti
Exclusively focused on North Carolina’s medical technology industry, ibiliti was a non-profit organization committed to assisting novel medical ideas reach market at optimal speed and minimal cost. In 2014, the organization was acquired by the North Carolina Hospital Association to work closely with member health systems to identify, develop and launch.
Jan 2011 - Jan 2014
Director Of Product Development
Venture funded specialty pharmaceutical specializing in commercialization of generic respiratory drug products based on proprietary dry powder inhalers. Oriel Therapeutics was acquired by Sandoz, the generic arm of Novartis in May 2010.
Oct 2007 - Dec 2010
Associate Director Biomedical Engineering
A fully integrated specialty pharmaceutical specializing in cardiovascular and respiratory disease - the 6th fastest growing company in the US (Fortune Sep2005). Acquired by Abbott in 2006 for $3.7 Billion.
2001 - 2007
~6 yrs
3 education records
Dan Deaton education
Msme, Mechanical Engineering
North Carolina State University
Mba
Unc Kenan-Flagler Business School
Bsme, Mechanical Engineering
North Carolina State University
FAQ
Frequently asked questions about Dan Deaton
Quick answers generated from the profile data available on this page.
What company does Dan Deaton work for?
Dan Deaton works for AstraZeneca.
What is Dan Deaton's role at AstraZeneca?
Dan Deaton is listed as Head of Inhaled Product Development at AstraZeneca at AstraZeneca.
What is Dan Deaton's email address?
AeroLeads has found 1 work email signal at @astrazeneca.com for Dan Deaton at AstraZeneca.
What is Dan Deaton's phone number?
AeroLeads has found 1 phone signal(s) with area code 714 for Dan Deaton at AstraZeneca.
Where is Dan Deaton based?
Dan Deaton is based in Raleigh-Durham-Chapel Hill Area, United States, United States while working with AstraZeneca.
What companies has Dan Deaton worked for?
Dan Deaton has worked for Astrazeneca, Triangle Angel Partners (Tap), Community Workforce Solutions, Polarean, Inc., and Grayscope Development.
How can I contact Dan Deaton?
You can use AeroLeads to view verified contact signals for Dan Deaton at AstraZeneca, including work email, phone, and LinkedIn data when available.
What schools did Dan Deaton attend?
Dan Deaton holds Msme, Mechanical Engineering from North Carolina State University.
What skills is Dan Deaton known for?
Dan Deaton is listed with skills including Medical Devices, Commercialization, Product Development, Cross Functional Team Leadership, Strategy, Strategic Planning, Start Ups, and Business Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial